Publication

Phage selection of cyclic peptide antagonists with increased stability toward intestinal proteases

Related publications (32)

About
Privacy
Disclaimer

Graph Chatbot

Chat with Graph Search

Ask any question about EPFL courses, lectures, exercises, research, news, etc. or try the example questions below.

DISCLAIMER: The Graph Chatbot is not programmed to provide explicit or categorical answers to your questions. Rather, it transforms your questions into API requests that are distributed across the various IT services officially administered by EPFL. Its purpose is solely to collect and recommend relevant references to content that you can explore to help you answer your questions.

Phage selection of cyclic peptide antagonists with increased stability toward intestinal proteases

Graph Chatbot

Chat with Graph Search

De novo developed small cyclic peptides that are orally available

Towards the Development of Orally Available Peptide Therapeutics

De novo development of proteolytically resistant therapeutic peptides for oral administration

Structure and Function of the T4 Spackle Protein Gp61.3

Generation of a Large Peptide Phage Display Library by Self-Ligation of Whole-Plasmid PCR Product

Structural and functional analysis of host attachment proteins from contractile injection systems

Development of cyclic peptide inhibitors of coagulation factor XII and matrix metalloproteinase 2

New methods for developing (bi)cyclic peptides by phage display

Phage Selection of Cyclic Peptides for Application in Research and Drug Development

Bypassing bacterial infection in phage display by sequencing DNA released from phage particles